The global companion animal healthcare market size was valued at USD 24.96 billion in 2025 and is projected to grow from USD 27.37 billion in 2026 to USD 57.28 billion by 2034, registering a CAGR of 9.67% during the forecast period (2026-2034). North America dominated the companion animal healthcare market with a share of 37.53% in 2025.
Companion animal healthcare refers to products, services, and treatments used to maintain, diagnose, and improve the health and well being of pets such as dogs and cats. Companion animal healthcare products and services are commonly tracked under HSN Code 3004 (medicaments for therapeutic or prophylactic uses) and SIC Code 0742 (Veterinary Services for Animal Specialties).
The companion animal healthcare market demand is driven by the growing pet population, high spending on preventive veterinary care, and a focus on pet diagnostics and animal diagnostics. Pet owners are increasingly using veterinary medicines, vaccines, diagnostic testing, nutritional products, preventive treatments, and digital health solutions, contributing to companion animal healthcare market growth.
By Product Type
By Therapeutic Area
By Animal Type
By Distribution Channel
Download a Free Sample To learn more about this report,
Integration of Wearable Devices with Companion Animal Health Monitoring
The companion animal healthcare market analysis shows the integration of wearable devices with companion animal health monitoring to track activity, sleep, heart rate, location, and other health-related indicators. Wearable devices can collect continuous data that can be reviewed by pet owners and veterinary professionals to identify changes in animal health and behavior.
Adoption of Nutritional and Therapeutic Pet Health Solutions
The companion animal healthcare market is witnessing growth in nutritional and therapeutic pet health solutions designed to address specific health and dietary needs of companion animals. These solutions include specialized diets, supplements, and therapeutic nutrition products targeting conditions such as digestive disorders, joint health, weight management, and aging-related needs.
Supply chain disruptions are expected to have a moderate impact on the companion animal healthcare market share due to dependence on veterinary medicines, animal vaccines, diagnostic products, medical devices, animal health ingredients, and specialized distribution networks. The market is expected to follow a stair-step recovery, as shortages of pharmaceutical ingredients, manufacturing delays, veterinary product constraints, and transportation disruptions can affect product availability in phases before production and distribution capacity stabilize. The market is expected to grow at a CAGR of 9.67%, but supply chain constraints could approximately lower this by 1.2 percentage points, resulting in short-term growth of around 8.47%. As supply conditions normalize through improved availability of veterinary medicines and vaccines, stable manufacturing capacity, smoother cold chain logistics, and improved veterinary distribution networks, companion animal healthcare market growth is expected to gradually return to 9.67%.
The companion animal healthcare market forecasts strategic investment activity driven by expansion of integrated veterinary care platforms, investment in digital veterinary technologies, and broader access to comprehensive care. In June 2026, Vetic raised USD 40 million in funding led by Bessemer Venture Partners to accelerate expansion of its integrated veterinary care platform, strengthen technology capabilities, and broaden access to preventive and specialized pet healthcare.
Demand for Personalized Veterinary Treatment and Expansion of Pet Insurance Coverage Drives Market
The demand for personalized veterinary treatment is growing as pet owners seek care based on the specific health needs of their animals. Veterinary providers are using diagnostic results, age, breed, and health history to choose suitable treatments. This focus on individual care is supporting demand for advanced companion animal healthcare services.
The expansion of pet insurance coverage is supporting spending on veterinary care by helping owners manage treatment costs. Insurance can improve access to diagnostic tests, medicines, surgeries, and other veterinary services. Greater financial support for pet healthcare is encouraging the use of professional veterinary care.
Limited Access to Specialized Veterinary Care and Risk of Adverse Effects from Veterinary Medications Restrain Market Expansion
Limited access to specialized veterinary care can restrict the adoption of advanced healthcare services for companion animals. Specialized treatments often require veterinary specialists, advanced diagnostic equipment, and dedicated facilities that may be concentrated in major cities and developed regions. Pet owners in rural or underserved areas may face long travel distances and higher costs to access such services.
The risk of adverse effects from veterinary medications can create concerns among pet owners and veterinarians. Certain medications may cause reactions such as gastrointestinal problems, allergic responses, or other treatment-related complications, particularly when dosing or administration is inappropriate. Safety concerns can influence medication use and restrain market expansion.
Expansion of Companion Animal Healthcare through Preventive Care and Pet Dental Care Offers Growth Opportunities
The focus on pet wellness is creating opportunities for veterinary clinics, pharmaceutical companies, and pet healthcare providers to serve owners seeking regular preventive care. Vaccinations, health checkups, parasite control, and routine screening can support early detection and disease prevention.
The awareness about pet oral health is creating opportunities for veterinary providers and animal healthcare companies to serve pet owners seeking dental care solutions. Dental examinations, cleaning procedures, oral care products, and veterinary dental treatments can support long-term pet health. Revenue can be generated through dental services, oral care products, and recurring veterinary programs, supporting market growth.
The parasiticides segment accounted for a share of 16.68% in 2025 due to the widespread use of products for preventing and treating parasites in companion animals.
The digital health & services segment is expected to grow at a CAGR of 15.26% during the forecast period, driven by the adoption of telehealth, digital veterinary records, remote monitoring, and technology-enabled pet care services.
Request Customizationto receive a tailored report.
The infectious diseases segment accounted for a share of 27.46% in 2025, owing to the continued need for diagnosis, prevention, and treatment of bacterial, viral, parasitic, and other infections in companion animals.
The oncology segment is expected to grow at a CAGR of 13.26% during the forecast period, propelled by increasing diagnoses of cancer in companion animals and greater availability of veterinary oncology services.
The dogs segment accounted for a share of 58.64% in 2025, supported by a large population of dogs receiving routine veterinary care, preventive treatments, vaccinations, and diagnostic services.
The cats segment is expected to grow at a CAGR of 10.48% during the forecast period, fueled by the adoption of cats as companion animals and growing awareness of preventive veterinary care.
The veterinary hospitals & clinics segment accounted for a share of 61.28% in 2025 due to their role in providing diagnosis, preventive care, treatment, surgery, vaccinations, and routine health monitoring.
The online platforms segment is expected to grow at a CAGR of 13.84% during the forecast period, driven by consumer adoption of digital purchasing channels for veterinary products, pet medicines, wellness products, and healthcare services.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Adoption of Veterinary Pharmaceuticals and Advance Veterinary Care
The North America companion animal healthcare market accounted for a share of 37.53% in 2025.
The U.S. companion animal healthcare market is supported by the adoption of veterinary pharmaceuticals. The U.S. Department of Agriculture’s Veterinary Biologics program continues to regulate and license vaccines and other biological products used in animal health, supporting the availability and development of veterinary medicines for companion animals.
The Canada companion animal healthcare market is shaped by the demand for veterinary medicine and veterinary pharmaceuticals. The Canadian Veterinary Medical Association continued initiatives to strengthen antimicrobial stewardship in veterinary practice, promoting responsible prescribing and use of veterinary medicines for companion animals.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Focus on Pet Nutrition and High Companion Animal Population
The Asia Pacific companion animal healthcare market is expected to grow at a CAGR of 11.45% during the forecast period, making it the fastest-growing region.
The China companion animal healthcare market is benefited by increasing demand for animal health products and specialized pet nutrition. China’s national pet industry initiatives are encouraging development of standardized pet food and animal health products, with greater attention to product quality, safety, and nutritional standards.
India’s companion animal population is projected to reach approximately 51.8 million by 2030, up from the 2025 base, with dogs continuing to represent the largest share of companion animals and cats recording comparatively faster population growth. This expanding animal population is expected to create additional demand for vaccinations, therapeutic drugs, diagnostic testing, veterinary consultations, and preventive healthcare services through 2030.
The Japan companion animal healthcare market is shaped by rising demand for specialized pet nutrition and animal health products. Japan’s Ministry of Agriculture, Forestry and Fisheries maintains regulatory standards for pet food safety under the Pet Food Safety Law, encouraging quality-controlled production and distribution of pet nutrition products.
Europe: Market Growth Supported by Demand for Pet Therapeutics and Preventive Care
The Europe companion animal healthcare market is expected to grow at a CAGR of 9.12% during the forecast period.
The Germany companion animal healthcare market is shaped by growing demand for pet therapeutics and preventive care. Germany’s Tiergesundheitsdienst initiatives provide structured disease prevention and health monitoring programs for animals, including veterinary diagnostics, vaccination guidance, and herd or population health measures, reflecting the country’s broader shift toward preventive veterinary care.
The UK companion animal healthcare market is driven by the UK’s Veterinary Medicines Directorate implementing the Small Animal Antimicrobial Stewardship Programme (SAAM), which collects prescribing data from veterinary practices and uses the results to promote responsible antimicrobial use in dogs and cats.
Latin America: Market Expansion Led by Focus on Companion Animal Wellness
The Latin America companion animal healthcare market is expected to grow at a CAGR of 10.26% during the forecast period. Brazil’s National Animal Health Program includes the expansion of veterinary diagnostic capacity and disease surveillance, supporting earlier detection of infectious diseases and strengthening diagnostic services across the animal health system. In Mexico, Humane World for Animals expanded its companion animal program in Aguascalientes through mobile veterinary clinics, providing preventive checkups, vaccinations, deworming, and referrals for specialized care, with the program targeting 6,000 animals during the year. This initiative is improving access to preventive and diagnostic veterinary services in underserved communities.
Middle East & Africa: Market Shaped by Preference for On-site Veterinary Consultations
The Middle East & Africa companion animal healthcare market is expected to grow at a CAGR of 9.78% during the forecast period. The UAE’s growing pet-friendly residential and lifestyle infrastructure is increasing demand for on-site veterinary consultations, preventive health checks, grooming-linked wellness services, and routine healthcare for companion animals. The South African Veterinary Council’s continuing professional development framework encourages veterinarians to maintain updated clinical skills, supporting the delivery of specialized and higher-quality veterinary services for companion animals.
The companion animal healthcare market competitive landscape is highly fragmented, with established animal health pharmaceutical companies, veterinary diagnostics providers, pet healthcare companies, and specialized animal health technology providers. Key players such as Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, and IDEXX Laboratories, Inc. are estimated to account for approximately 35–40% of the global companion animal healthcare market share.
Established players compete mainly through preventive healthcare products, clinical research capabilities, and global distribution networks. Emerging and regional players in the companion animal healthcare market ecosystem focus on digital health solutions and application-specific pet healthcare technologies.
September 2026: Zoetis launched Lenivia in Great Britain, a long acting monoclonal antibody therapy designed to provide up to three months of osteoarthritis pain relief for dogs.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Animal Microchip Implant Market Size, Share, Growth, 2034
Pet Care Market Size, Share, Growth, Analysis, Report, 2034
Veterinary Pharmaceutical Drugs Market Size, Share, Growth, 2034
Veterinary Point of Care Diagnostics Market Size, Share, 2034
Veterinary Electrosurgery Market Size, Share, Growth, Analysis, 2034
Fipronil Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com